Back to search

Norway· NO-ID_7B4BA0DB-9CC4-40A1-A550-8F004300E92B

Methylthioninium chloride Proveblue

A methylthioninium chloride product containing metyltioninklorid, registered in Norway by Provepharm SAS. The same ATC class is registered in 12 of our 19 countries.

ATC V03AB17

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedMethylthioninium chloride ProveblueATCV03AB17REGISTER NO.NO-ID_7B4BA0DB-9CC4-4…PACKS LISTED5CHECKEDOctober 2, 2026

Where it is registered

Methylthioninium chloride is registered in 12 of 19 countries.

Countries holding a registration under ATC V03AB17 (methylthioninium chloride), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 7 of them publish a price we can compare per daily dose

Methylthioninium chloride · ATC V03AB17

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Metyltioninklorid
Manufacturer
Provepharm SAS
Country
Norway (NO)
ATC code
V03AB17
ATC class
Methylthioninium chloride
Defined daily dose
0.105 g, P
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
October 2, 2026

Packs & prices · 5

2 priced
  • no_merkevare_id
    ID_7B4BA0DB-9CC4-40A1-A550-8F004300E92B
  • no_varenummer
    413220
    5 x 10
    NOK 3055.8
  • no_varenummer
    467153
    5 x 2
    NOK 2872.1
  • gtin
    7046264132203
  • gtin
    7046264671535

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

213 interactions on record for methylthioninium chloride.

Graded by severity as the source publishes them — 141 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Methylthioninium chloride · interactions on record

213 records

  • 141 severe
  • 71 moderate
  • 1 minor

Most severe, free to view

  • IsomethepteneA03AX10severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6cf42623-6eae-4dc5-b220-9437b08f3eec
GET /v1/drugs/6cf42623-6eae-4dc5-b220-9437b08f3eec?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Injeksjonsvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Metyltioninklorid",
  "merkevare_id": "ID_7B4BA0DB-9CC4-40A1-A550-8F004300E92B",
  "name_form_strength": "Methylthioninium chloride Proveblue inj, oppl 5 mg/ml",
  "prescription_group": "C"
}

See everything about methylthioninium chloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.